Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine (Vaccines, 2024)

(untitled) - Wee, EG; Kempster, S; Ferguson, D; Hall, J; Ham, C; Morris, S; Crook, A; Gilbert, SC; Korber, B; Almond, N; Hanke, T